4/A//SEC Filing
Chondros Dimitrios 4/A
Accession 0001179110-19-002193
CIK 0001159036other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:10 PM ET
Size
5.5 KB
Accession
0001179110-19-002193
Insider Transaction Report
Form 4/AAmended
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2019-02-03$16.41/sh−2,536$41,616→ 31,566 total
Footnotes (1)
- [F1]On February 5, 2019, the reporting person filed a Form 4 reporting the disposition of 2,503 shares at a price of $16.12 per share representing the shares that were sold to pay minimum statutory tax withholding obligations due upon vesting of 6,165 restricted stock award shares. This report is being filed to correct the transaction code, the total number of shares sold, the price per share received upon disposition and the aggregate beneficial ownership of the reporting person as of February 3, 2019, which will be updated in Forms 4 filed after the date of this amendment.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001739693
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 8:10 PM ET
- Size
- 5.5 KB